Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That is factually wrong they don't die at a higher rate on leronlimab actually even at 24% it was still twice as effective as SOC at day 28
It is counter intuitive to make an argument that LL is saline and point to the unjust enrichment lawsuit at the same time. That lawsuit was brought by wealthy, former insiders who are knowledgeable about the potential for LL
82% reduction in 14 day mortality for critical (intubated) covid patients, with p=0.023
Leronlimab's detractors love to hammer on the P-Value of Primary End Points in Leronlimab studies. That's because they have ZERO credible ammunition to train on the science behind what Leronlimab does to the patients in those studies.
LL needs to be taken for longer to extend that 14 day benefit.
Cytodyn should use that in a Covid commercial.
Leronlimab....it will add 2 weeks to your life....well probably!
Leronlimab didn’t kill covid did
I spent a few weeks on Utila in 1994. I loved it. Obviously, it was super touristy even then but it attracted a great type of traveler. I really liked the afro-latino culture of Utila and Ceiba, too. Way better food than the other parts of the country.
82% reduction in mortality at 14 days.
My third house is on an island off the coast of Honduras.
And if 2 placebo patients had survived instead of passed away, the 24% efficacy would be gone. Seriously, all of the efficacy in the 62 patient critical cohort would be gone with 2 more placebo patients living.
The science of Leronlimab has not changed, just your feelings.
Does anyone have a link to the article that Rockleo wrote?
pvalue is more important than lives
Do you follow Yang around?
When will go Janet and her club to jail?
There is a reason that the trial sites are being increased for the NIH study, need to increase enrollment to hit P value
Just watched Video again so if a patient is in ECMO leronlimab will get them out of ECMO in 1/2 the time of remdesivir 2 to 3 days sooner at the cost in Manila hospitals by today’s exchange to dollars of $20,670 a day. The cost of leronlimab compared to others with wholesale buys would make it equal or better plus less side effects WOW no brainer
We do know what Dr. Yang thinks. It is PUBLISHED in a paper dated 10/20/2020. It is accessible on CYDY website.
Remdesivir, which the Philippines has been purchasing through CSP
$10,000 a patient WOW guess they won’t be using that in Philippines or Brazil and South America’s other poor countries
None , from anyone , he disclosed that today during the testimonies
Nader has obviously taken other options, revealing his opposition to diluting shares.
How much money do you think Chiral is giving to Dr Randy Nicholas?
Credibility gone.
Don't you guys get why Donx4 is here. He is absolutely terrified that Leronlimab will be a success and the impact that it will have on his investment in Lenz. Why spend so much time on this board trying to discredit Leronlimab.
HGEN's Cameron Durrant has been very clear that 100,000 patients can be treated in 2021 at a cost of $10,000 per treatment. So when they say dose, they aren't talking about a third of a treatment. One vial equals 1,800mg which gets divided into 3 sessions spaced 8 hours apart.
And yet, the topic is what Dr. Yang thinks. And that is that LL can and has saved lives.
Dr. Yang watched LL save his patients life. He told us all of his experience.
Was lenz denied OLE? I don't understand why lenz doesn't have OLE, wouldn't the company want to continue treating patients in the trial?
He has publicly come out in support of LL
I don't wish for any life saving drug to fail.
the only things Dr. Yang has said publicly about Leronlimab are positive and in support.
Actually that's incorrect DonDon. Lenzilumab takes 3 doses to treat, so those 100,000 doses that take 12 months to make will treat 33,333 patients in 2021, not 100,000 patients.
I believe very recently to Dr Woodcocck..
Mediocre??? They met all primary and secondary endpoints in their trial. Please do not post false information.
Dr Yang
Nothing in this article relates directly to Lenzilumab. Also, what about the bradykinin storm?
Same thing with Le Zulu Mab. Three changes to meet watered down endpoint
and no inventory ready for a year to treat a minimal amount of patients.
The reason Leronlimab will have difficulty getting any approvals in Covid is because the path would show the incompetence of the FDA with their own statements how ridiculous they look. Blood on their hands would be obvious.
I'm honestly surprised that the NeuroRX/Relief fight didn't drop the stock price more than it did. Trial results are mediocre. It is pretty clear that HGEN's GM-CSF inhibitor drug lenzilumab is going to take over the severe/critical arena because the cytokine GM-CSF is the key to preventing severe Covid and death.
https://www.bbc.com/news/health-56352128